molecular markers of bladder cancer: from the particular to the general
Clicks: 280
ID: 203075
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
280 views
36 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #17 of 50 articles by views in supportive care in cancer
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Bladder cancer (BC) is the second most common urinary tract malignancy. Early diagnosis of BC generally increases the probability of successful treatment in a patient. The paper considers noninvasive diagnosis methods for BC and gives a database of the known molecular markers of this disease.
| Reference Key |
zabolotneva2014onkourologimolecular
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;A. A. Zabolotneva;N. M. Gaifullin;A. A. Buzdin;B. Ya. Alekseyev;Yu. Yu. Andreyeva;P. V. Shegai;D. G. Sokov;I. G. Rusakov |
| Journal | supportive care in cancer |
| Year | 2014 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.